|
1
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mantovani A and Sica A: Macrophages,
innate immunity and cancer: Balance, tolerance, and diversity. Curr
Opin Immunol. 22:231–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arango Duque G and Descoteaux A:
Macrophage cytokines: Involvement in immunity and infectious
diseases. Front Immunol. 5:4912014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ojalvo LS, King W, Cox D and Pollard JW:
High-density gene expression analysis of tumor-associated
macrophages from mouse mammary tumors. Am J Pathol. 174:1048–1064.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP,
Wu C and Zheng L: Activated monocytes in peritumoral stroma of
hepatocellular carcinoma foster immune privilege and disease
progression through PD-L1. J Exp Med. 206:1327–1337. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Williams CB, Yeh ES and Soloff AC:
Tumor-associated macrophages: Unwitting accomplices in breast
cancer malignancy. NPJ Breast Cancer. 2:22016. View Article : Google Scholar
|
|
7
|
Krneta T, Gillgrass A, Poznanski S, Chew
M, Lee AJ, Kolb M and Ashkar AA: M2-polarized and tumor-associated
macrophages alter NK cell phenotype and function in a
contact-dependent manner. J Leukoc Biol. 101:285–295. 2017.
View Article : Google Scholar
|
|
8
|
Crane CA, Austgen K, Haberthur K, Hofmann
C, Moyes KW, Avanesyan L, Fong L, Campbell MJ, Cooper S, Oakes SA,
et al: Immune evasion mediated by tumor-derived lactate
dehydrogenase induction of NKG2D ligands on myeloid cells in
glioblastoma patients. Proc Natl Acad Sci USA. 111:12823–12828.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Z, Zhang C, Zhang J and Tian Z:
Macrophages help NK cells to attack tumor cells by stimulatory
NKG2D ligand but protect themselves from NK killing by inhibitory
ligand Qa-1. PLoS One. 7:e369282012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen MJ, Xu LJ, Yang L, Tsai Y, Keng PC
and Chen Y, Lee SO and Chen Y: Radiation alters PD-L1/NKG2D ligand
levels in lung cancer cells and leads to immune escape from NK cell
cytotoxicity via IL-6-MEK/Erk signaling pathway. Oncotarget.
8:80506–80520. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mu CY, Huang JA, Chen Y, Chen C and Zhang
XG: High expression of PD-L1 in lung cancer may contribute to poor
prognosis and tumor cells immune escape through suppressing tumor
infiltrating dendritic cells maturation. Med Oncol. 28:682–688.
2011. View Article : Google Scholar
|
|
12
|
Afreen S and Dermime S: The
immunoinhibitory B7-H1 molecule as a potential target in cancer:
Killing many birds with one stone. Hematol Oncol Stem Cell Ther.
7:1–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nausch N and Cerwenka A: NKG2D ligands in
tumor immunity. Oncogene. 27:5944–5958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Shen M, Xu LJ, Yang X, Tsai Y,
Keng PC, Chen Y and Lee SO: Enhancing NK cell-mediated cytotoxicity
to cisplatin-resistant lung cancer cells via MEK/Erk signaling
inhibition. Sci Rep. 7:79582017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Yang X, Tsai Y, Yang L, Chuang KH,
Keng PC, Lee SO and Chen Y: IL-6 mediates macrophage infiltration
after irradiation via up-regulation of CCL2/CCL5 in non-small cell
lung cancer. Radiat Res. 187:50–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aarons CB, Bajenova O, Andrews C, Heydrick
S, Bushell KN, Reed KL, Thomas P, Becker JM and Stucchi AF:
Carcinoembryonic antigen-stimulated THP-1 macrophages activate
endothelial cells and increase cell-cell adhesion of colorectal
cancer cells. Clin Exp Metastasis. 24:201–209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Genin M, Clement F, Fattaccioli A, Raes M
and Michiels C: M1 and M2 macrophages derived from THP-1 cells
differentially modulate the response of cancer cells to etoposide.
BMC Cancer. 15:5772015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Korzeniewski C and Callewaert DM: An
enzyme-release assay for natural cytotoxicity. J Immunol Methods.
64:313–320. 1983. View Article : Google Scholar
|
|
19
|
Decker T and Lohmann-Matthes ML: A quick
and simple method for the quantitation of lactate dehydrogenase
release in measurements of cellular cytotoxicity and tumor necrosis
factor (TNF) activity. J Immunol Methods. 115:61–69. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi L, Lin H, Li G, Sun Y, Shen J, Xu J,
Lin C, Yeh S, Cai X and Chang C: Cisplatin enhances NK cells
immunotherapy efficacy to suppress HCC progression via altering the
androgen receptor (AR)-ULBP2 signals. Cancer Lett. 373:45–56. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith SM, Wunder MB, Norris DA and
Shellman YG: A simple protocol for using a LDH-based cytotoxicity
assay to assess the effects of death and growth inhibition at the
same time. PLoS One. 6:e269082011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu L, Chen X, Shen M, Yang DR, Fang L,
Weng G, Tsai Y, Keng PC, Chen Y and Lee SO: Inhibition of
IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer
cells enhances the NK cell-mediated cytotoxicity via alteration of
PD-L1/NKG2D ligand levels. Mol Oncol. 12:269–286. 2018. View Article : Google Scholar :
|
|
23
|
Lee Y, Auh SL, Wang Y, Burnette B, Wang Y,
Meng Y, Beckett M, Sharma R, Chin R, Tu T, et al: Therapeutic
effects of ablative radiation on local tumor require
CD8+ T cells: Changing strategies for cancer treatment.
Blood. 114:589–595. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Xu H, Lai W, Zhang Y, Liu L, Luo X, Zeng
Y, Wu H, Lan Q and Chu Z: Tumor-associated macrophage-derived IL-6
and IL-8 enhance invasive activity of LoVo cells induced by PRL-3
in a KCNN4 channel-dependent manner. BMC Cancer. 14:3302014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Yoshida S, Kubo Y, Yoshimura T,
Kobayashi Y, Nakama T, Yamaguchi M, Ishikawa K, Oshima Y and
Ishibashi T: Different distributions of M1 and M2 macrophages in a
mouse model of laser-induced choroidal neovascularization. Mol Med
Rep. 15:3949–3956. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nawaz A, Aminuddin A, Kado T, Takikawa A,
Yamamoto S, Tsuneyama K, Igarashi Y, Ikutani M, Nishida Y, Nagai Y,
et al: CD206+ M2-like macrophages regulate systemic
glucose metabolism by inhibiting proliferation of adipocyte
progenitors. Nat Commun. 8:2862017. View Article : Google Scholar
|
|
28
|
Xu L, Shen M, Chen X, Yang DR, Tsai Y,
Keng PC, Lee SO and Chen Y: In vitro-induced M2 type macrophages
induces the resistance of prostate cancer cells to cytotoxic action
of NK cells. Exp Cell Res. 364:113–123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Benson DM Jr, Bakan CE, Mishra A,
Hofmeister CC, Efebera Y, Becknell B, Baiocchi RA, Zhang J, Yu J,
Smith MK, et al: The PD-1/PD-L1 axis modulates the natural killer
cell versus multiple myeloma effect: A therapeutic target for
CT-011, a novel monoclonal anti-PD-1 antibody. Blood.
116:2286–2294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang BY, Zhan YP, Zong WJ, Yu CJ, Li JF,
Qu YM and Han S: The PD-1/B7-H1 pathway modulates the natural
killer cells versus mouse glioma stem cells. PLoS One.
10:e01347152015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bae DS, Hwang YK and Lee JK: Importance of
NKG2D-NKG2D ligands interaction for cytolytic activity of natural
killer cell. Cell Immunol. 276:122–127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
González S, López-Soto A, Suarez-Alvarez
B, López-Vázquez A and López-Larrea C: NKG2D ligands: Key targets
of the immune response. Trends Immunol. 29:397–403. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Niemand C, Nimmesgern A, Haan S, Fischer
P, Schaper F, Rossaint R, Heinrich PC and Müller-Newen G:
Activation of STAT3 by IL-6 and IL-10 in primary human macrophages
is differentially modulated by suppressor of cytokine signaling 3.
J Immunol. 170:3263–3272. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li YY, Hsieh LL, Tang RP, Liao SK and Yeh
KY: Interleukin-6 (IL-6) released by macrophages induces IL-6
secretion in the human colon cancer HT-29 cell line. Hum Immunol.
70:151–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bellucci R, Martin A, Bommarito D, Wang K,
Hansen SH, Freeman GJ and Ritz J: Interferon-γ-induced activation
of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells
through upregulation of PD-L1 expression. OncoImmunology.
4:e10088242015. View Article : Google Scholar
|
|
36
|
Ikeda S, Okamoto T, Okano S, Umemoto Y,
Tagawa T, Morodomi Y, Kohno M, Shimamatsu S, Kitahara H, Suzuki Y,
et al: PD-L1 is upregulated by simultaneous amplification of the
PD-L1 and JAK2 genes in non-small cell lung cancer. J Thorac Oncol.
11:62–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fujita Y, Yagishita S, Hagiwara K,
Yoshioka Y, Kosaka N, Takeshita F, Fujiwara T, Tsuta K, Nokihara H,
Tamura T, et al: The clinical relevance of the
miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant
non-small-cell lung cancer. Mol Ther. 23:717–727. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Marzec M, Zhang Q, Goradia A, Raghunath
PN, Liu X, Paessler M, Wang HY, Wysocka M, Cheng M, Ruggeri BA, et
al: Oncogenic kinase NPM/ALK induces through STAT3 expression of
immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci
USA. 105:20852–20857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lastwika KJ, Wilson W III, Li QK, Norris
J, Xu H, Ghazarian SR, Kitagawa H, Kawabata S, Taube JM, Yao S, et
al: Control of PD-L1 expression by oncogenic activation of the
AKT-mTOR pathway in non-small cell lung cancer. Cancer Res.
76:227–238. 2016. View Article : Google Scholar
|
|
40
|
Gowrishankar K, Gunatilake D, Gallagher
SJ, Tiffen J, Rizos H and Hersey P: Inducible but not constitutive
expression of PD-L1 in human melanoma cells is dependent on
activation of NF-κB. PLoS One. 10:e01234102015. View Article : Google Scholar
|
|
41
|
Yamamoto R, Nishikori M, Tashima M, Sakai
T, Ichinohe T, Takaori-Kondo A, Ohmori K and Uchiyama T: B7-H1
expression is regulated by MEK/ERK signaling pathway in anaplastic
large cell lymphoma and Hodgkin lymphoma. Cancer Sci.
100:2093–2100. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen N1, Fang W, Zhan J, Hong S, Tang Y,
Kang S, Zhang Y, He X, Zhou T, Qin T, et al: Upregulation of PD-L1
by EGFR activation mediates the immune escape in EGFR-driven NSCLC:
Implication for optional immune targeted therapy for NSCLC patients
with EGFR mutation. J Thorac Oncol. 10:910–923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu C, Fillmore CM, Koyama S, Wu H, Zhao Y,
Chen Z, Herter-Sprie GS, Akbay EA, Tchaicha JH, Altabef A, et al:
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with
elevated PD-L1 expression. Cancer Cell. 25:590–604. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Noh H, Hu J, Wang X, Xia X, Satelli A and
Li S: Immune checkpoint regulator PD-L1 expression on tumor cells
by contacting CD11b positive bone marrow derived stromal cells.
Cell Commun Signal. 13:142015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dehai C, Bo P, Qiang T, Lihua S, Fang L,
Shi J, Jingyan C, Yan Y, Guangbin W and Zhenjun Y: Enhanced
invasion of lung adenocarcinoma cells after co-culture with
THP-1-derived macrophages via the induction of EMT by IL-6. Immunol
Lett. 160:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Condeelis J and Pollard JW: Macrophages:
Obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu CY, Xu JY, Shi XY, Huang W, Ruan TY,
Xie P and Ding JL: M2-polarized tumor-associated macrophages
promoted epithelial-mesenchymal transition in pancreatic cancer
cells, partially through TLR4/IL-10 signaling pathway. Lab Invest.
93:844–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hattermann K, Sebens S, Helm O, Schmitt
AD, Mentlein R, Mehdorn HM and Held-Feindt J: Chemokine expression
profile of freshly isolated human glioblastoma-associated
macrophages/microglia. Oncol Rep. 32:270–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jeong SK, Kim JS, Lee CG, Park YS, Kim SD,
Yoon SO, Han DH, Lee KY, Jeong MH and Jo WS: Tumor associated
macrophages provide the survival resistance of tumor cells to
hypoxic microenvironmental condition through IL-6 receptor-mediated
signals. Immunobiology. 222:55–65. 2017. View Article : Google Scholar
|
|
50
|
Lee SO, Lou W, Johnson CS, Trump DL and
Gao AC: Interleukin-6 protects LNCaP cells from apoptosis induced
by androgen deprivation through the Stat3 pathway. Prostate.
60:178–186. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jeannin P, Duluc D and Delneste Y: IL-6
and leukemia-inhibitory factor are involved in the generation of
tumor-associated macrophage: Regulation by IFN-γ. Immunotherapy.
3(Suppl 4): 23–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Scheller J, Chalaris A, Schmidt-Arras D
and Rose-John S: The pro- and anti-inflammatory properties of the
cytokine interleukin-6. Biochim Biophys Acta. 1813:878–888. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Topalian SL, Hodi FS, Brahmer JR,
Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD,
Sosman JA, Atkins MB, et al: Safety, activity, and immune
correlates of anti-PD-1 antibody in cancer. N Engl J Med.
366:2443–2454. 2012. View Article : Google Scholar : PubMed/NCBI
|
